Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China

prnasiaSeptember 13, 2021

Tag: JW Therapeutics , Relmacabtagene Autoleucel , CAR-T product , NMPA Approval

PharmaSources Customer Service